STATE OF WISCONSIN INVESTMENT BOARD
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 854157
MADISON, WI
Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,385,902
+$1,596,336 QoQ
Shares Held
427,513
+38.6% QoQ
Ownership
0.234%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#48
of 238 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026STATE OF WISCONSIN INVESTMENT BOARD holds $154,808,435 across 36 Drug Manufacturers - Specialty & Generic names. XERS ranks #12 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
293,025 | $21,056,776 | |
| 2 | VTRS |
Viatris Inc
|
1,319,328 | $20,950,928 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
87,254 | $14,705,789 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
115,962 | $12,864,824 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
365,722 | $12,390,661 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
22,483 | $12,181,963 | |
| 7 | LQDA |
Liquidia Corp
|
98,858 | $7,881,948 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
305,624 | $7,521,406 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,385,902 | 427,513 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,789,566 | 308,546 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,806,006 | 357,453 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,853,306 | 350,529 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,298,353 | 278,020 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $111,309 | 20,275 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||